Hypertension in patients presenting with stroke.
Hypertension is a major risk factor for stroke disease. There is now some international agreement on what constitutes hypertension, and at what level of blood pressure treatment is required. Large randomised controlled trials demonstrate the benefit of reducing blood pressure for the primary and secondary prevention of stroke disease. Studies have also demonstrated the benefit of particular classes of antihypertensive agents in certain patient groups. Research is beginning to elucidate the problems of hypertension in the acute phase of ischaemic stroke and the therapeutic strategies that may be helpful. Given the significant impact of stroke disease on all health services, it remains an important priority to determine the best management of hypertension in stroke.
Pearson
B J
BJ
Division of Stroke Medicine, University of Nottingham, Hucknall Road, Nottingham NG5 1PB, United Kingdom.
Bath
P M
PM
Spence
J D
JD
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D012307:Risk Factors; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control; D016896:Treatment Outcome
D000959:Antihypertensive Agents